On July 3, 2026, Swiss clinical boards updated their guidance on importing specialized cancer therapeutics under Swissmedic personal-use regulations. For Swiss patients with refractory solid tumors, accessing novel immunotherapies and targeted biologics from global pipelines can be a crucial path when local markets experience lag times.

At Onco Medicine, we track Swissmedic guidelines closely. Sourcing and distributing original oncology drugs with verified cold-chain logistics allows Swiss medical teams to offer uninterrupted care programs with maximum safety.

Swiss Oncology Sourcing & Standards

• Swissmedic Compliance: Swiss law allows personal importation of a limited supply of prescription medicines with a valid medical prescription from a Swiss-licensed physician.
• Biological Pipeline Integration: Accessing global batches of Keytruda or subcutaneous Herceptin ensures treatment plans can proceed without interruption from local stock shortages.
• High-Precision Logistics: Temperature-controlled packing and end-to-end telemetry are mandatory when delivering to Swiss clinical networks.

Precision treatment demands flawless execution at every level. From our specialized global storage facilities to direct clinical delivery, Onco Medicine remains a trusted partner in ensuring Swiss cancer patients receive authentic, life-saving therapies when they need them most.